Lovelace Biomedical
Lovelace Biomedical is a not-for-profit preclinical contract research organization specializing in advancing new therapies, assessing drug and toxicant risks, and characterizing disease using comprehensive in vivo and in vitro models. Leveraging a GLP-compliant facility and scientific collaborations, the organization provides expertise in toxicology, gene therapy, respiratory, infectious disease, neuroscience, and cell biology, with a commitment to quality, regulatory compliance, and advanced analytical capabilities.
Industries
N/A
Services
Nonclinical toxicology assessments including study design, execution, and reporting under GLP standards.
Bioanalysis, dose formulation analysis, and analytical chemistry support for preclinical and clinical studies.
Development and optimization of drug formulations for use in preclinical animal studies.
Comprehensive PK and TK evaluations for characterization of drug behavior in biological systems.
Design and execution of in vivo and in vitro pharmacology studies in multiple therapeutic areas.
Veterinary care, housing, and husbandry of research animals supporting high-quality, ethical preclinical research.
Nonclinical toxicology assessments including study design, execution, and reporting under GLP standards.
Bioanalysis, dose formulation analysis, and analytical chemistry support for preclinical and clinical studies.
Development and optimization of drug formulations for use in preclinical animal studies.
Comprehensive PK and TK evaluations for characterization of drug behavior in biological systems.
Design and execution of in vivo and in vitro pharmacology studies in multiple therapeutic areas.
Veterinary care, housing, and husbandry of research animals supporting high-quality, ethical preclinical research.
Expertise Areas
- Preclinical research
- GLP toxicology
- Gene therapy development
- Respiratory disease modeling
Key Technologies
- Animal models
- Bioanalytical method validation
- In vivo studies
- Histopathology
Key People
Chief Executive Officer
Executive Vice President, Chief Operating Officer
Senior Director, Pharmacology
Attending Veterinarian
Research Veterinarian
Veterinary Pathologist
Chief Executive Officer
Executive Vice President, Chief Operating Officer
Senior Director, Pharmacology
Attending Veterinarian
Research Veterinarian
Veterinary Pathologist
News & Updates
Lovelace Biomedical’s scientist Conor Ruzycki recognized as co-author of a high-impact manuscript in the Journal of Aerosol Medicine.
Article discussing the potential impact of host-directed therapies on future pandemic preparedness.
Covers crucial considerations for biotech companies pursuing federal research contracts.
Article focusing on strategies for making preclinical research more impactful.
Overview of safety concerns in RNA therapeutics and the role of preclinical research.
Insights from the Society of Toxicology annual meeting.
Lovelace Biomedical’s scientist Conor Ruzycki recognized as co-author of a high-impact manuscript in the Journal of Aerosol Medicine.
Article discussing the potential impact of host-directed therapies on future pandemic preparedness.
Covers crucial considerations for biotech companies pursuing federal research contracts.
Article focusing on strategies for making preclinical research more impactful.
Overview of safety concerns in RNA therapeutics and the role of preclinical research.
Insights from the Society of Toxicology annual meeting.